Eppendorf continues on course for success
The Eppendorf Group successfully ended fiscal year 2016 with Group sales of €651.5 million (prior year: €629.1 million) and revenue growth of 3.6% (4.8% when adjusted for currency effects). Income from operations (EBIT) climbed 17.1% to €139.6 million (prior year: €119.3 million), amounting to an EBIT margin of 21.4% (prior year: 19.0%).
The Asian market and the services segment in particular contributed to this good result. During the reporting year, Eppendorf significantly increased expenses for research and development to €34.8 million (prior year: €31.9 million). In addition, the company expanded its global service and sales presence, among other things through the acquisition of a company in Ireland.
“Once again, we can look back on a good fiscal year. We want to continue developing dynamically and are currently working on a variety of measures to ensure we achieve profitable growth in the future as well,” said Thomas Bachmann, President & Chief Executive Officer of Eppendorf AG. “In addition to carrying out various internal projects, we took the step early this year, for instance, of acquiring a controlling interest in the Dutch company Bio-ITech B.V. after working closely with them last year on device and data networking.”
In 2017, the company will continue to focus on product and application development as well as on the ongoing expansion of its sales, development and production sites.
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Genetically harmful compounds detected in vegetable oils - Genotoxins discovered for the first time using a novel method
How atomic nuclei vibrate
BEAM | FT-NIR process spectrometers | Bruker
Graphene plasmons go ballistic - Graphene combined with the insulting power of boron nitride enables light control in tiny circuits with dramatically reduced energy loss
Bridging the gap
Searching tissue with words - From pathology image to biological discovery: A journey with LazySlide
Lighting up Alzheimer’s-related proteins to allow for earlier disease detection
InnovationsAward for Postnova at analytica 2008
Nanotubes: cellular membranes on supply - Osmotic forces play a role in nanotube formation in cells